Sign In
Buy CNCE
$8.37
+0 (+0%)
At Close: May 30, 2023
The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Hologic To Launch Coronavirus Test, Amarin's Strong Q1
12:00am, Thursday, 30'th Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs April 29)
• Arvinas Inc (NASDAQ...
Concert (CNCE) Moves to Buy: Rationale Behind the Upgrade
04:00pm, Wednesday, 29'th Apr 2020
Concert (CNCE) has been upgraded to a Zacks Rank 2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks: Brokerages Anticipate Concert Pharmaceuticals Inc (NASDAQ:CNCE) Will Announce Earnings of -$0.74 Per Share
09:56am, Wednesday, 29'th Apr 2020
Equities research analysts predict that Concert Pharmaceuticals Inc (NASDAQ:CNCE) will report earnings of ($0.74) per share for the current fiscal quarter, Zacks Investment Research reports. Two analy
Concert (CNCE) Moves to Buy: Rationale Behind the Upgrade
12:00am, Wednesday, 29'th Apr 2020FDA Warns Manufacturers and Retailers to Remove Certain E-cigarette Products
03:53pm, Monday, 27'th Apr 2020
FDA Warns Manufacturers and Retailers to Remove Certain E-cigarette Products | STL.News | Read health related news on STL.News.
The Week Ahead In Biotech (April 26-May 2): Cancer Conference, Earnings News Flow In The Spotlight
08:37pm, Sunday, 26'th Apr 2020
The week ended April 24 turned out to be an up-and-down one for biotech stocks, as the sector swayed along with the broader market. Two FDA approvals came through this week, with Immunomedics, Inc.'s
Concert Pharmaceuticals to Report First Quarter 2020 Financial Results on April 30, 2020
11:00am, Thursday, 23'rd Apr 2020
Concert will report its first quarter 2020 financial results and host a conference call and webcast on April 30, 2020.
Why Concert Pharmaceuticals (CNCE) Stock Might be a Great Pick
12:55pm, Wednesday, 15'th Apr 2020
Concert Pharmaceuticals (CNCE) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well
Mizuho Securities Maintains a Buy Rating on Concert Pharma (CNCE)
08:12am, Wednesday, 15'th Apr 2020
In a report released today, Difei Yang from Mizuho Securities maintained a Buy rating on Concert Pharma (CNCE), with a price target of $18.00. The
Mizuho Securities Maintains a Buy Rating on Concert Pharma (CNCE)
08:12am, Wednesday, 15'th Apr 2020
In a report released today, Difei Yang from Mizuho Securities maintained a Buy rating on Concert Pharma (CNCE – Research
Why Concert Pharmaceuticals (CNCE) Stock Might be a Great Pick
12:00am, Wednesday, 15'th Apr 2020Farmasi rented a 2,500 sqm warehouse in CTPark Bucharest - Business Review
09:17am, Tuesday, 14'th Apr 2020
Dunwell secures 2,500 sqm of warehouse for Farmasi, producer and distributor of cosmetical and hygiene products at CTP, the biggest developer of
Concert Pharmaceuticals (NASDAQ:CNCE) Cut to Hold at Zacks Investment Research
10:32am, Sunday, 12'th Apr 2020
Zacks Investment Research downgraded shares of Concert Pharmaceuticals (NASDAQ:CNCE) from a buy rating to a hold rating in a research report released on Wednesday, Zacks.com reports. According to Zack
Concert Pharmaceuticals (NASDAQ:CNCE) Lifted to "Buy" at Zacks Investment Research
10:04am, Tuesday, 07'th Apr 2020
Zacks Investment Research upgraded shares of Concert Pharmaceuticals (NASDAQ:CNCE) from a hold rating to a buy rating in a report issued on Monday morning, Zacks.com reports. The brokerage currently h
